Treb schreef op 8 december 2015 14:15:
Fagron, one of our core positions and a company with an amazing track
record and strong management, incurred reimbursement issues in the
US. The stock price overreacted in a volatile environment and caused
a significant drag on the Fund. The shares are clearly undervalued now
and the company has announced that it has been approached by several
interested parties. A take-out price will have to be significantly above
the current depressed levels, so we are confident we can recover value,
either organically as the company recovers from the set-back or short term
through a take-out.